Vaccination with soluble headless hemagglutinin protects mice from challenge with divergent influenza viruses. - Wikidata - wikimedia - TriplyDB

Vaccination with soluble headless hemagglutinin protects mice from challenge with divergent influenza viruses.

Vaccination with soluble headless hemagglutinin protects mice from challenge with divergent influenza viruses.

http://www.wikidata.org/entity/Q35756765

about

Heterosubtypic T-Cell Immunity to Influenza in Humans: Challenges for Universal T-Cell Influenza Vaccines Novel universal influenza virus vaccine approaches Stalking influenza by vaccination with pre-fusion headless HA mini-stem Globular Head-Displayed Conserved Influenza H1 Hemagglutinin Stalk Epitopes Confer Protection against Heterologous H1N1 Virus.Broadly Neutralizing Hemagglutinin Stalk-Specific Antibodies Induce Potent Phagocytosis of Immune Complexes by Neutrophils in an Fc-Dependent Manner.A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.Antibody-Dependent Cell-Mediated Cytotoxicity Epitopes on the Hemagglutinin Head Region of Pandemic H1N1 Influenza Virus Play Detrimental Roles in H1N1-Infected Mice Sequential Infection in Ferrets with Antigenically Distinct Seasonal H1N1 Influenza Viruses Boosts Hemagglutinin Stalk-Specific Antibodies.Age Dependence and Isotype Specificity of Influenza Virus Hemagglutinin Stalk-Reactive Antibodies in Humans.IGHV1-69 polymorphism modulates anti-influenza antibody repertoires, correlates with IGHV utilization shifts and varies by ethnicity Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact.Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus.Preferential induction of cross-group influenza A hemagglutinin stem-specific memory B cells after H7N9 immunization in humans.Influenza A Viruses Expressing Intra- or Intergroup Chimeric Hemagglutinins.A Perspective on the Structural and Functional Constraints for Immune Evasion: Insights from Influenza Virus.Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies.From Original Antigenic Sin to the Universal Influenza Virus Vaccine.Vaccine approaches conferring cross-protection against influenza viruses.A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies.A chimeric haemagglutinin-based influenza split virion vaccine adjuvanted with AS03 induces protective stalk-reactive antibodies in mice.Development of a novel dual-domain nanoparticle antigen construct for universal influenza vaccine.Structural insights into the design of novel anti-influenza therapies.

P2860

Q26744622-866F3571-1474-4D2A-BC1D-089D7863F010 Q30385071-06182C24-3D76-4D19-AFA7-EF8CAC7CB065 Q30385331-A1EE3362-89B6-49C0-AE11-EF2923DB7D9F Q30387031-60BF0D5C-6F7C-4DD4-AB49-1C01010E69AF Q30393724-FCBFE5B3-761F-4704-941C-859A3668193E Q30398406-824C47E2-B9BA-4CED-B418-E164441221BE Q30400732-44ED868A-211C-4E6C-9E0E-B898E057ED12 Q36434265-8E323B18-7FBE-45CB-850A-DF49FD92D7F9 Q36496580-D2FC18AD-153E-4EB4-A0A6-0C8A5D1616E8 Q36583070-E7C040BB-4286-4ED2-932D-4EB7EF73C8E9 Q37323172-9342146F-0C00-4D5D-9F22-8D729CA95815 Q37369509-F9BF5650-8821-47A2-A2A7-E709C81D74A8 Q38636861-E937E114-E66B-444E-9FE7-7EDE701055E1 Q38803889-2155405E-1A9B-4A3D-B5C4-A1E981752458 Q39397313-700AD56B-A152-453B-BDBA-94360B2B3C29 Q40057948-67CFBBA7-B9A8-4C53-967B-68735FB58D8D Q40059787-ACE95A7F-ABA4-464A-A8BD-5CF9971E0272 Q41934895-5F6E8FDD-AD3A-4891-B093-2F0B33F22FDD Q47108278-5F2DDD81-8E0F-4625-9DEF-A8FAE5B62137 Q47132783-E3CFAB6B-720A-4370-A07E-0DD523D1C1AB Q47442073-D7F41384-E611-4DBB-B4D4-A81EB716190A Q48113181-A0DDF441-6AB9-413A-8610-494124010B21

P2860

Vaccination with soluble headless hemagglutinin protects mice from challenge with divergent influenza viruses.

http://www.wikidata.org/entity/Q35756765

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Vaccination with soluble headl ...... h divergent influenza viruses.

@ast

Vaccination with soluble headl ...... h divergent influenza viruses.

@en

type

label

Vaccination with soluble headl ...... h divergent influenza viruses.

@ast

Vaccination with soluble headl ...... h divergent influenza viruses.

@en

prefLabel

Vaccination with soluble headl ...... h divergent influenza viruses.

@ast

Vaccination with soluble headl ...... h divergent influenza viruses.

@en

P1433

Q35756765-EFC43231-7235-4AC2-AB35-8DE8E9831CAA

P1476

Q35756765-E86D07CD-3412-4D10-ADD6-4FA9E9E31FEA

P2093

Q35756765-4C11C58A-2CE2-4B0F-BAD5-A48B1B1ED98D

Q35756765-68EDA011-C4B2-4966-9FA0-C5D13C7E447C

Q35756765-B9FDA9E4-7251-4564-B79F-AC0E50270A0A

P2860

Q35756765-03CA5817-4E01-437F-B55E-F049F0572020

Q35756765-07546248-213B-42F1-BE8C-F180E6678993

Q35756765-0761657B-9FF5-41CF-A560-F95B1AF64B15

Q35756765-0FAF9C60-D955-4FF8-A83D-4C0166A7A3BF

Q35756765-13670FCD-007E-40D7-9557-646607C90E94

Q35756765-156073D7-6EEA-470F-BF06-1AFE2E2687BE

Q35756765-186C2CF4-234E-4711-9EBA-F9E2F80228B1

Q35756765-1CC190E5-8D15-460E-B74A-A53874D1ED89

Q35756765-23B59C8E-B788-48E5-A974-B49483D961BB

Q35756765-2CE7B575-ADFC-41EE-A0A9-03F601F1DDBD

P304

Q35756765-7E9A558C-C90C-4928-9C79-6A3F97D9887B

P31

Q35756765-1507934D-4B77-4B6A-9E9B-6E537DB0F807

P356

Q35756765-6B0C8191-348B-4D36-98CE-336FA9FF6DE4

P407

Q35756765-DF18F381-D936-4824-980F-066A16B00D2B

P433

Q35756765-765D0CEA-8D36-46DA-AD53-9906A5F51CE7

P478

Q35756765-C42192F7-D120-4EC3-A3E5-60F43BBBBBBB

P50

Q35756765-50E0BB71-DCB3-4474-ABDE-3F2B7523C1FE

Q35756765-6AC81114-89E4-4D89-A9BA-5F733B2BF19B

Q35756765-A4DAF904-1C37-4AFD-BC53-9B106F7FC475

P577

Q35756765-4A1BA0FE-88A0-4AD8-B633-92BEA1FD0D18

P5875

Q35756765-FDB47BA1-3ADD-443E-AD7E-5F125CC5F560

P698

Q35756765-87222477-8D2A-4211-92FF-C33CC75C50C2

P932

Q35756765-34EFC3A6-4307-4688-BE11-BE2FEDA0A06C

P356

J.VACCINE.2015.05.038

P1433

P1476

Vaccination with soluble headl ...... h divergent influenza viruses.

@en

P2093

Ariana Hirsh

http://www.w3.org/2001/XMLSchema#string

Irina Margine

http://www.w3.org/2001/XMLSchema#string

Teddy John Wohlbold

http://www.w3.org/2001/XMLSchema#string

P2860

Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo

Rapid cloning of high-affinity human monoclonal antibodies against influenza virus

Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses

Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza

Antibody recognition of a highly conserved influenza virus epitope

Influenza-specific antibody-dependent cellular cytotoxicity: toward a universal influenza vaccine

Influenza virus hemagglutinin stalk-based antibodies and vaccines

A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins

A common solution to group 2 influenza virus neutralization

Influenza: old and new threats

P304

3314-3321

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.VACCINE.2015.05.038

http://www.w3.org/2001/XMLSchema#string

P407

P433

29

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P50

Raffael Nachbagauer

Florian Krammer

P577

2015-05-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277478025

http://www.w3.org/2001/XMLSchema#string

P698

26026378

http://www.w3.org/2001/XMLSchema#string

P932

4472732

http://www.w3.org/2001/XMLSchema#string